Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

1(33%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_1

33%

Ph not_applicable

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution2 total trials

Phase 1Safety & dosage

1(50.0%)

N/ANon-phased studies

1(50.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(2)

Detailed Status

Completed2

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 11 (50.0%)

N/A1 (50.0%)

Trials by Status

completed267%

recruiting133%

Recent Activity

1 active trials

Showing 3 of 3

recruitingnot_applicable

The Effects of Preoperative Intranasal Administration of Dexmedetomidine and Esketamine on Negative Postoperative Behavioral Changes in Children With Autism Spectrum Disorder

NCT07324057

completed

Intranasal Esketamine to Maintain the Antidepressant Response to IV Racemic Ketamine

NCT04856124

completedphase_1

A Study to Evaluate the Effects of Esketamine on Cardiac Repolarization in Healthy Participants

NCT02737605

Clinical Trials (3)

Showing 3 of 3 trials

NCT07324057Not Applicable

The Effects of Preoperative Intranasal Administration of Dexmedetomidine and Esketamine on Negative Postoperative Behavioral Changes in Children With Autism Spectrum Disorder

Recruiting

NCT04856124

Intranasal Esketamine to Maintain the Antidepressant Response to IV Racemic Ketamine

Completed

NCT02737605Phase 1

A Study to Evaluate the Effects of Esketamine on Cardiac Repolarization in Healthy Participants

Completed

All 3 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 3